據(jù)安迅思倫敦5月31日消息，朗盛公司和Advent公司周二表示，兩家公司將收購(gòu)荷蘭專(zhuān)用化學(xué)品公司帝斯曼旗下工程材料部門(mén)，并打算將該部門(mén)與朗盛自己的高性能材料業(yè)務(wù)合并。

在帝斯曼宣布計(jì)劃與總部位于瑞士的香精香料公司Firmenich合并數(shù)小時(shí)后，這家荷蘭公司同意出售其工程材料業(yè)務(wù)，標(biāo)志著該公司最終轉(zhuǎn)型為一家健康、營(yíng)養(yǎng)和生物科學(xué)專(zhuān)業(yè)公司。

Advent將支付約37億歐元收購(gòu)帝斯曼工程材料業(yè)務(wù)。帝斯曼工程材料業(yè)務(wù)將與朗盛公司旗下高性能材料業(yè)務(wù)合并成立一家合資公司，總部位于美國(guó)的私人股本公司Advent將成為合資公司的控股股東。

兩家公司表示，Advent將向朗盛額外支付11億歐元，朗盛公司將在合資公司中持有約40%的股份。

這筆交易預(yù)計(jì)將于2023年上半年完成，合并后的帝斯曼/朗盛業(yè)務(wù)預(yù)計(jì)將實(shí)現(xiàn)約30億歐元的年銷(xiāo)售額。

龐曉華 摘譯自 ICIS

原文如下：

LANXESS, Advent to acquire DSM engineering materials arm, establish joint 

LANXESS and Advent are to acquire the engineering materials division of Netherlands-based specialties player DSM, the companies said on Tuesday, with an eye to merging the operations with LANXESS’ own high-performance materials business.

Coming hours after an announcement by DSM of plans to merge with Switzerland-based flavours and fragrances player Firmenich, the Dutch company agreed to sell its engineering materials business, signalling its final transformation into a health, nutrition, and biosciences specialist.

Advent is to pay around 3.7bn for the DSM business, which is to be folded into a joint venture with LANXESS high-performance materials business, with the US-headquartered private equity firm to stand as the majority owner of the combined operations.

Advent is to pay out an additional 1.1bn to LANXESS, with the Germany-based chemicals business to hold a stake of around 40% in the joint venture, the companies said.

The deal is expected to close in the first half of 2023, with the combined DSM/LANXESS business expected to have combined annual sales of around 3bn.